SummaryBackgroundIn France, the reported decrease in cardiovascular death is due partly to improved cardiovascular prevention. The management of dyslipidaemias remains a priority of preventive cardiology.AimTo assess trends in lipids, lipoproteins and dyslipidaemias between 1996 and 2007 in France.MethodsRepresentative surveys of the general population were carried out in Lille, Strasbourg and Toulouse during two periods, 1996 to 1997 and 2006 to 2007. Men and women aged 35 to 64 years were included. Investigators recorded cardiovascular risk factors, and a blood sample was drawn to measure glycaemia and to provide a complete lipid profile. The data were corrected according to the respective original populations to study 10-year trends in t...
Background: Dyslipidemia, an increased level of total cholesterol (TC), triglycerides (TG), low-dens...
Guidelines recommend lowering LDL-cholesterol (LDL-c) according to level of cardiovascular risk. We ...
Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CV...
SummaryBackgroundIn France, the reported decrease in cardiovascular death is due partly to improved ...
SummaryBackgroundResidual dyslipidaemia in patients treated with statins needs to be addressed to re...
PurposeAlthough statins are the cornerstone of cardiovascular (CV) prevention, patients (pts) treate...
PurposeCurrent guidelines recommend lowering LDL-cholesterol below 2.6 mmol/L in patients with estab...
PurposeThe beneficial effect of lipid-lowering drugs on cardiovascular mortality is well established...
SummaryObjectiveMost evidence-based practice guidelines identify low-density lipoprotein cholesterol...
SummaryBackgroundThe frequencies of treatment for cardiovascular risk factors are poorly documented ...
We assessed 1) trends in prevalence, awareness, treatment and control rates of dyslipidaemia and ass...
Introduction –Les objectifs de la présente étude étaient de décrire le cholestérol LDL (LDLc) moyen,...
BACKGROUND:Blood lipid profile of French men and women obtained from the general population is not w...
PurposeTo assess ten-year change in the prevalence of the metabolic syndrome among French subjects u...
Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CV...
Background: Dyslipidemia, an increased level of total cholesterol (TC), triglycerides (TG), low-dens...
Guidelines recommend lowering LDL-cholesterol (LDL-c) according to level of cardiovascular risk. We ...
Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CV...
SummaryBackgroundIn France, the reported decrease in cardiovascular death is due partly to improved ...
SummaryBackgroundResidual dyslipidaemia in patients treated with statins needs to be addressed to re...
PurposeAlthough statins are the cornerstone of cardiovascular (CV) prevention, patients (pts) treate...
PurposeCurrent guidelines recommend lowering LDL-cholesterol below 2.6 mmol/L in patients with estab...
PurposeThe beneficial effect of lipid-lowering drugs on cardiovascular mortality is well established...
SummaryObjectiveMost evidence-based practice guidelines identify low-density lipoprotein cholesterol...
SummaryBackgroundThe frequencies of treatment for cardiovascular risk factors are poorly documented ...
We assessed 1) trends in prevalence, awareness, treatment and control rates of dyslipidaemia and ass...
Introduction –Les objectifs de la présente étude étaient de décrire le cholestérol LDL (LDLc) moyen,...
BACKGROUND:Blood lipid profile of French men and women obtained from the general population is not w...
PurposeTo assess ten-year change in the prevalence of the metabolic syndrome among French subjects u...
Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CV...
Background: Dyslipidemia, an increased level of total cholesterol (TC), triglycerides (TG), low-dens...
Guidelines recommend lowering LDL-cholesterol (LDL-c) according to level of cardiovascular risk. We ...
Surveys measuring effectiveness of public awareness campaigns in reducing cardiovascular disease (CV...